Skip to content

Resistance in archived virus dissimilar to circulating virus in patients on failing treatment

Resistance already emerging in first months of treatment despite viral load decline

Is there any clinical benefit to staying on a failing regimen?

Further development of resistance infrequent in patients taking tenofovir despite low-level viremia and K65R mutation

CROI: Sexually transmitted infections significantly increase risk of drug-resistant HIV transmission

CROI: Recent OIs or AIDS strongest predictors of development of resistance in South African first-line failures

CROI: Further evidence that short-course PMTCT prophylaxis compromises mother's future treatment

CROI: Effects of transmitted drug resistance on viral load are drug class specific

Health Canada issues warning on use of Baraclude alone in HIV/hepatitis B coinfected